From: The future outlook on allergen immunotherapy in children: 2018 and beyond
Major gaps in the evidence of prevention | |
---|---|
❖ Long-term effectiveness of AIT in preventing asthma in children with AR due to grass pollen | |
❖ Effectiveness of AIT in preventing asthma in children with AR due to house dust mites | |
❖ Identification of the optimal age for introduction of AIT for prevention | |
❖ Identification of the optimal duration of AIT for prevention | |
❖ Identification of the optimal product, administration form, dose and schedule of AIT for prevention | |
❖ Evaluation of healthy economics of AIT for prevention | |
❖ Evaluation of acceptability of AIT for prevention in different patient groups (age, pattern of sensitization and clinical characteristics) and healthy individuals | |
❖ Identification of the most suitable candidates | |
❖ “Precision preventive medicine” algorithms |